BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24043770)

  • 21. Sequestration of a β-hairpin for control of α-synuclein aggregation.
    Mirecka EA; Shaykhalishahi H; Gauhar A; Akgül Ş; Lecher J; Willbold D; Stoldt M; Hoyer W
    Angew Chem Int Ed Engl; 2014 Apr; 53(16):4227-30. PubMed ID: 24623599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonenzymatic polyubiquitination of expressed proteins.
    Hemantha HP; Bavikar SN; Herman-Bachinsky Y; Haj-Yahya N; Bondalapati S; Ciechanover A; Brik A
    J Am Chem Soc; 2014 Feb; 136(6):2665-73. PubMed ID: 24437386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha-synuclein implies Lewy body biogenesis.
    Liu C; Fei E; Jia N; Wang H; Tao R; Iwata A; Nukina N; Zhou J; Wang G
    J Biol Chem; 2007 May; 282(19):14558-66. PubMed ID: 17360705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insights into ubiquitin chain architecture using Ub-clipping.
    Swatek KN; Usher JL; Kueck AF; Gladkova C; Mevissen TET; Pruneda JN; Skern T; Komander D
    Nature; 2019 Aug; 572(7770):533-537. PubMed ID: 31413367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the linkage dependence of polyubiquitin conformations using molecular modeling.
    Fushman D; Walker O
    J Mol Biol; 2010 Jan; 395(4):803-14. PubMed ID: 19853612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of atypical diubiquitin chains.
    Oualid FE; Hameed DS; Atmioui DE; Hilkmann H; Ovaa H
    Methods Mol Biol; 2012; 832():597-609. PubMed ID: 22350915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation.
    Lim KL; Chew KC; Tan JM; Wang C; Chung KK; Zhang Y; Tanaka Y; Smith W; Engelender S; Ross CA; Dawson VL; Dawson TM
    J Neurosci; 2005 Feb; 25(8):2002-9. PubMed ID: 15728840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated α-synuclein.
    Hejjaoui M; Haj-Yahya M; Kumar KS; Brik A; Lashuel HA
    Angew Chem Int Ed Engl; 2011 Jan; 50(2):405-9. PubMed ID: 21154793
    [No Abstract]   [Full Text] [Related]  

  • 31. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.
    Kim YM; Jang WH; Quezado MM; Oh Y; Chung KC; Junn E; Mouradian MM
    J Neurol Sci; 2011 Aug; 307(1-2):157-61. PubMed ID: 21641618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alpha-synuclein post-translational modifications on metal binding.
    González N; Arcos-López T; König A; Quintanar L; Menacho Márquez M; Outeiro TF; Fernández CO
    J Neurochem; 2019 Sep; 150(5):507-521. PubMed ID: 31099098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.
    Covell DJ; Robinson JL; Akhtar RS; Grossman M; Weintraub D; Bucklin HM; Pitkin RM; Riddle D; Yousef A; Trojanowski JQ; Lee VM
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):604-620. PubMed ID: 28386933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein engineering of a ubiquitin-variant inhibitor of APC/C identifies a cryptic K48 ubiquitin chain binding site.
    Watson ER; Grace CRR; Zhang W; Miller DJ; Davidson IF; Prabu JR; Yu S; Bolhuis DL; Kulko ET; Vollrath R; Haselbach D; Stark H; Peters JM; Brown NG; Sidhu SS; Schulman BA
    Proc Natl Acad Sci U S A; 2019 Aug; 116(35):17280-17289. PubMed ID: 31350353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Synuclein aggregation and modulating factors.
    Paleologou KE; El-Agnaf OM
    Subcell Biochem; 2012; 65():109-64. PubMed ID: 23225002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteasome-independent functions of lysine-63 polyubiquitination in plants.
    Romero-Barrios N; Vert G
    New Phytol; 2018 Feb; 217(3):995-1011. PubMed ID: 29194634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
    Sahay S; Ghosh D; Singh PK; Maji SK
    Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semisynthesis and Enzymatic Preparation of Post-translationally Modified α-Synuclein.
    Fauvet B; Lashuel HA
    Methods Mol Biol; 2016; 1345():3-20. PubMed ID: 26453202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.